FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3119063518> ?p ?o ?g. }

• W3119063518 endingPage "932" @default.
• W3119063518 startingPage "926" @default.
• W3119063518 abstract "In 2017, a new adjuvanted recombinant zoster vaccine (RZV) was recommended for adults ≥50 years as two-dose series 2-6 months apart. We evaluated two-dose RZV completion and factors associated with completion.The study included Kaiser Permanente Southern California members ≥50 years who received an RZV dose during April-November 2018 and had continuous membership 12 months before to 9 months after the first RZV dose. Completion was defined as receipt of the second dose ≥4 weeks to 9 months after the first dose (allowing 3-month grace period). Characteristics including age, sex, race/ethnicity, Medicaid status, neighborhood level income and education, comorbidities, history of zoster, health care utilization before and after the first dose, receipt of influenza vaccine, vaccination month (supply shortage proxy), concomitant vaccine, medical center, and medically attended reactions, pain, or gout after the first dose were compared between completers and non-completers. Adjusted odds ratios and 95% confidence intervals for factors associated with completion were estimated by multivariable logistic regression.Among 31,120 first dose recipients, 67.2% completed the series within 9 months. In adjusted analyses, higher completion was associated with White compared with Black or Hispanic race/ethnicity, higher neighborhood income and education, no chronic pulmonary disease, diabetes, or dementia, more outpatient visits and fewer emergency department visits before or after the first dose, no hospitalizations after the first dose, receipt of influenza vaccine, receipt of the first dose in June-November rather than April-May 2018, and no concomitant vaccine with the first dose. Systemic reactions or pain after the first dose was not associated with completion.Completion of RZV series appears suboptimal in the early phase of implementation. Despite similar accessibility in a health care system, completion varied by race/ethnicity, socioeconomic status, health status, and care seeking behavior, suggesting areas to target for improvement." @default.
• W3119063518 created "2021-01-18" @default.
• W3119063518 creator A5002800668 @default.
• W3119063518 creator A5008238011 @default.
• W3119063518 creator A5026569333 @default.
• W3119063518 creator A5036366931 @default.
• W3119063518 creator A5059798670 @default.
• W3119063518 creator A5068600661 @default.
• W3119063518 creator A5081863034 @default.
• W3119063518 creator A5090765456 @default.
• W3119063518 creator A5091472574 @default.
• W3119063518 date "2021-02-01" @default.
• W3119063518 modified "2023-10-01" @default.
• W3119063518 title "Completion of the two-dose recombinant zoster vaccine series in adults 50 years and older" @default.
• W3119063518 cites W1123392853 @default.
• W3119063518 cites W1508759738 @default.
• W3119063518 cites W1640057351 @default.
• W3119063518 cites W1980040599 @default.
• W3119063518 cites W1988737996 @default.
• W3119063518 cites W1992354372 @default.
• W3119063518 cites W2010207831 @default.
• W3119063518 cites W2055967275 @default.
• W3119063518 cites W2086658590 @default.
• W3119063518 cites W2093246726 @default.
• W3119063518 cites W2103762134 @default.
• W3119063518 cites W2106873166 @default.
• W3119063518 cites W2116805191 @default.
• W3119063518 cites W2131041950 @default.
• W3119063518 cites W2329705186 @default.
• W3119063518 cites W2519957152 @default.
• W3119063518 cites W2528404210 @default.
• W3119063518 cites W2772112182 @default.
• W3119063518 cites W2784682748 @default.
• W3119063518 cites W2790367141 @default.
• W3119063518 cites W2808856055 @default.
• W3119063518 cites W2809738454 @default.
• W3119063518 cites W2883266876 @default.
• W3119063518 cites W2991762457 @default.
• W3119063518 cites W4247276518 @default.
• W3119063518 doi "https://doi.org/10.1016/j.vaccine.2020.12.076" @default.
• W3119063518 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33441234" @default.
• W3119063518 hasPublicationYear "2021" @default.
• W3119063518 type Work @default.
• W3119063518 sameAs 3119063518 @default.
• W3119063518 citedByCount "15" @default.
• W3119063518 countsByYear W31190635182021 @default.
• W3119063518 countsByYear W31190635182022 @default.
• W3119063518 countsByYear W31190635182023 @default.
• W3119063518 crossrefType "journal-article" @default.
• W3119063518 hasAuthorship W3119063518A5002800668 @default.
• W3119063518 hasAuthorship W3119063518A5008238011 @default.
• W3119063518 hasAuthorship W3119063518A5026569333 @default.
• W3119063518 hasAuthorship W3119063518A5036366931 @default.
• W3119063518 hasAuthorship W3119063518A5059798670 @default.
• W3119063518 hasAuthorship W3119063518A5068600661 @default.
• W3119063518 hasAuthorship W3119063518A5081863034 @default.
• W3119063518 hasAuthorship W3119063518A5090765456 @default.
• W3119063518 hasAuthorship W3119063518A5091472574 @default.
• W3119063518 hasBestOaLocation W31190635182 @default.
• W3119063518 hasConcept C126322002 @default.
• W3119063518 hasConcept C144024400 @default.
• W3119063518 hasConcept C149923435 @default.
• W3119063518 hasConcept C151956035 @default.
• W3119063518 hasConcept C156957248 @default.
• W3119063518 hasConcept C160735492 @default.
• W3119063518 hasConcept C162324750 @default.
• W3119063518 hasConcept C187212893 @default.
• W3119063518 hasConcept C203014093 @default.
• W3119063518 hasConcept C22070199 @default.
• W3119063518 hasConcept C2776534028 @default.
• W3119063518 hasConcept C2779384505 @default.
• W3119063518 hasConcept C44249647 @default.
• W3119063518 hasConcept C50522688 @default.
• W3119063518 hasConcept C71924100 @default.
• W3119063518 hasConceptScore W3119063518C126322002 @default.
• W3119063518 hasConceptScore W3119063518C144024400 @default.
• W3119063518 hasConceptScore W3119063518C149923435 @default.
• W3119063518 hasConceptScore W3119063518C151956035 @default.
• W3119063518 hasConceptScore W3119063518C156957248 @default.
• W3119063518 hasConceptScore W3119063518C160735492 @default.
• W3119063518 hasConceptScore W3119063518C162324750 @default.
• W3119063518 hasConceptScore W3119063518C187212893 @default.
• W3119063518 hasConceptScore W3119063518C203014093 @default.
• W3119063518 hasConceptScore W3119063518C22070199 @default.
• W3119063518 hasConceptScore W3119063518C2776534028 @default.
• W3119063518 hasConceptScore W3119063518C2779384505 @default.
• W3119063518 hasConceptScore W3119063518C44249647 @default.
• W3119063518 hasConceptScore W3119063518C50522688 @default.
• W3119063518 hasConceptScore W3119063518C71924100 @default.
• W3119063518 hasIssue "6" @default.
• W3119063518 hasLocation W31190635181 @default.
• W3119063518 hasLocation W31190635182 @default.
• W3119063518 hasLocation W31190635183 @default.
• W3119063518 hasOpenAccess W3119063518 @default.
• W3119063518 hasPrimaryLocation W31190635181 @default.
• W3119063518 hasRelatedWork W152238595 @default.
• W3119063518 hasRelatedWork W2011313051 @default.
• W3119063518 hasRelatedWork W2037611947 @default.

• next